Quimpac1.Lm

QuimPac1 has a debt-to-equity ratio of 0.63, indicating a moderate reliance on debt financing, and a current ratio of 1.31, suggesting it has sufficient short-term assets to cover its short-term liabilities. However, the company's free cash flow is negative at -11.8 million, and its operating cash flow is 109.1 million, which may signal pressure on liquidity despite a relatively strong operating performance.

The company's profitability is reflected in a return on equity (ROE) of 7.12% and a return on assets (ROA) of 3.39%, both of which are below the typical thresholds for high-performing chemical firms. These metrics suggest that QuimPac1 is generating returns, but not at a level that would be considered exceptional within the industry.

QuimPac1's revenue is concentrated in the chemicals segment, with no disclosed geographic diversification in the provided data. This lack of geographic segmentation may expose the company to regional economic fluctuations and regulatory changes that could impact its overall performance.

The company's growth trajectory is not clearly defined in the provided data, as there are no forward-looking revenue projections or historical growth rates available. The absence of a clear growth narrative may make it difficult to assess the company's long-term potential.

The risk assessment indicates a medium liquidity risk and a low dilution risk. The company's net cash position is negative after subtracting total debt, which could affect its ability to fund operations or invest in growth opportunities without external financing.

There are no recent events or filings provided in the data that would indicate significant changes in the company's operations or strategic direction. The absence of recent disclosures may suggest a stable but uneventful period for QuimPac1.